NCT03113006View on ClinicalTrials.gov

The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT)

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Proliferative Diabetic RetinopathyPDRDiabetes
Interventions
PROCEDURE

Panretinal Photocoagulation

Panretinal laser treatment of the retina in patients with proliferative diabetic retinopathy.

Trial Locations (1)

5000

The Department of Ophthalmology, Odense University Hospital, Odense

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

collaborator

Velux Fonden

OTHER

lead

Odense University Hospital

OTHER

NCT03113006 - The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) | Biotech Hunter | Biotech Hunter